Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk Models.

Although the inclusion of a 313 genetic variant PRS doubles discriminatory accuracy (relative to reference 0.50), models with and without this PRS have relatively modest discrimination and might require recalibration before their clinical and wider use are promoted.